Since 2014, Sven Kuhlendahl has been General Manager of PROGEN Biotechnik GmbH. He is currently transforming one of Heidelberg’s oldest biotech company into a modern, dynamic player in the research antibodies market.
On his way to this appointment, Sven gained extensive expertise at Becton Dickinson in business development, marketing and sales management positions. He started his business career in 1998 at Boehringer Ingelheim after acquiring a PhD in Cell Biology at the University of Alabama at Birmingham / USA.
For the past 16 years Sven has been directly involved with the regional biotech community on many levels. In numerous business transactions including technology transfer, licensing and large-scale commercial deals, he has built solid relationships with Heidelberg’s research community and with companies ranging from small start-ups to global players.